HealthQuill Drugs
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.
Drugs Health

India grapples with thalassaemia crisis with 42 million carriers

HQ Team May 8, 2025: As the world observes World Thalassaemia Day on May 8, India faces a harsh reality—it is often called.

Read More
Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child and maternal deaths, combat infectious diseases, Alzheimer’s, and close down the Gates Foundation on December 31, 2045.
Drugs Health Medical

Gates Foundation to shut in 2045, pledges $200 billion in next 20 years

HQ Team May 8, 2025: Billionaire Bill Gates will donate more than $200 billion over the next two decades to prevent newborn child.

Read More
Caring for the elderly
Drugs Opinion

Tailored dementia care: Strategies for enhancing quality of life at home

Alvina Miller May7 2025: Dementia, a term used to describe a group of cognitive impairments, significantly impacts the quality of life of affected.

Read More
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health Medical

Addressing India’s asthma crisis: Ensuring access to treatments for all

HQ Team May 7, 2025: It was World Asthma Day on May 6, and let us see how India has fared in the.

Read More
Nuravax Inc. and its partner, the Institute for Molecular Medicine, have received a $3 million grant from the National Institutes of Health to advance its Alzheimer’s vaccine to human trials.
Drugs Health Pharma

Nuravax’s Alzheimer’s vaccine gets $3m grant to enter human trials

HQ Team May 5, 2025: Nuravax Inc. and its partner, the Institute for Molecular Medicine, have received a $3 million grant from the.

Read More
Scientists have developed a test by studying how an abnormally-shaped protein in the spinal fluid can detect 90% of Parkinson’s disease in patients, even before symptoms appear.
Drugs Health Research

New Parkinson’s test to detect disease even before symptoms appear

HQ Team May 5, 2025: Scientists have developed a test by studying how an abnormally-shaped protein in the spinal fluid can detect 90%.

Read More
The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and urged enhanced surveillance, biosecurity measures and preparations for a potential human-to-human transmission.
Drugs Health Pharma

Global virologists see potential for an H5N1 pandemic, urge rapid steps

HQ Team May 5, 2025: The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and.

Read More
UK scientists at biotech company Stablepharma have developed a tetanus-diphtheria vaccine that is completely stable at room temperature and does not need to be refrigerated or frozen.
Drugs Health Pharma

UK company starts trial on first ‘fridge-free’ tetanus-diphtheria vaccine

HQ Team May 1, 2025: UK scientists at biotech company Stablepharma Ltd. have developed a tetanus-diphtheria vaccine that is completely stable at room.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer therapy, nivolumab (Opdivo), offering a quicker administration option for eligible patients than the currently available drip treatment. 
Drugs Medical Pharma

UK regulator clears subcutaneous injection of Bristol Myers for cancers

HQ Team May 1, 2025: Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer.

Read More
Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a drug to treat a genetic kidney disease called autosomal dominant polycystic kidney disease.
Drugs Health Pharma

Novartis buys Regulus for $1.7b to grab genetic kidney disease drug

HQ Team April 30, 2025: Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a.

Read More